scholarly journals Sodium chloride bath – A cheap and safe tool for antiparasitic treatment of fish

2021 ◽  
Author(s):  
J Lanikova ◽  
P Mikula ◽  
J Blahova ◽  
F Tichy ◽  
J Mares ◽  
...  
Keyword(s):  
Sodium Chloride ◽  
Parasitic Infections ◽  
Control Groups ◽  
Short Term ◽  
Short Term Exposure ◽  
Treated Fish ◽  
The Common ◽  
C 30 ◽  
Safe Approach ◽  
Antiparasitic Treatment

Sodium chloride is widely used in aquaculture due to its antiparasitic effects and its ability to reduce stress during fish transport and manipulation. The aim of this study was to assess the safety of short-term exposure to sodium chloride for the common carp (Cyprinus carpio). In our experiment, fish were placed into a sodium chloride bath (c = 30 g l<sup>–1</sup>; T = 30 min; t = 20 °C) and the effects of the treatment were assessed immediately after the bath (T0) and 24, 48 and 240 h later (T24, T48 and T240, respectively), with non-treated fish serving as control groups. Though significant differences compared to the controls were observed in the treated fish sampled at T0, T24 and T48, these effects were only temporary and all the affected parameters (i.e., haemoglobin, haematocrit, plasmatic lactate, cholesterol, alanine aminotransferase, albumin, phosphorus and ceruloplasmin) had completely recovered within 10 days of exposure, suggesting that the treatment of carp with a sodium chloride bath represents a safe approach suitable for therapy of parasitic infections.

scholarly journals Dose- and Time-Dependent Micronucleus Induction in Peripheral Erythrocytes of Catfish, Heteropneustes fossilis (Bloch) by Zinc

2014 ◽  
Vol 9 ◽  
pp. 36-43 ◽  
Author(s):  
Soumendra Nath Talapatra ◽  
Priya Banerjee ◽  
Aniruddha Mukhopadhyay
Keyword(s):  
Time Dependent ◽  
Test Model ◽  
Heteropneustes Fossilis ◽  
Control Groups ◽  
Short Term ◽  
Effluent Quality ◽  
Short Term Exposure ◽  
Micronucleus Induction ◽  
Suitable Measure

As far as the detection of metal genotoxicity in fish is concerned, micronucleus (MN) test is considered an extremely suitable measure. In this study, frequencies of micronucleated erythrocytes were scored in peripheral blood of catfish, Heteropneustes fossilis (bloch) after acute in-vivo exposure of zinc at different concentrations (5, 10 and 30 ppm) in the laboratory condition. These three concentrations of zinc were tested at different durations such as 24h, 48h, 72h and 96h respectively. Highly significant (P < 0.001) increased values were obtained for MN frequencies in the peripheral erythrocytes of exposed fishes compared to control groups of fishes. These results confirm that dose- and time-dependent micronucleation in the peripheral erythrocytes of fish after short-term exposure to zinc could provide valuable information regarding zinc containing effluent quality and also help in genetic biomonitoring with this test model. In this context safe concentration of zinc vis-a-vis genotoxicity range could be evaluated for future studies.

scholarly journals Cerium oxide nanoparticles induced physio-biochemical, neurochemical, and morphological responses in Cirrhinus mrigala during short term exposure

2021 ◽  
pp. 51-61
Author(s):  
Kalpesh Swamy ◽  
Naveenkumar Chandrashekar ◽  
Raghunandhakumar Subramanian ◽  
Sandya Sukumaran ◽  
Sharath Chandra
Keyword(s):  
Oxidative Stress ◽  
Cerium Oxide ◽  
Biological Effects ◽  
Hematological Parameters ◽  
High Concentration ◽  
Control Groups ◽  
Short Term ◽  
Cirrhinus Mrigala ◽  
Short Term Exposure ◽  
Different Doses

Cerium oxide nanoparticle (CeO2NPs) has wide applications in pharmaceutical, biomedical and chemical industries. Albeit of their uses, bioavailability followed by toxicity of CeO2NPs in fresh water fishes, are yet to be understood in detail. In this evaluation, we have synthesized, characterized and assessed the biological effects (hematology, ionoregulatory, oxidative stress, histological and glutamate indices) of CeO2NPs at different doses (2.5mg/L and 25mg/L based on 1/10th LC50) on freshwater carps Cirrhinus mrigala, for short term exposure of 96 h. Impact of CeO2NPs at low concentration (2.5mg/L) confirmed a significant decrease in hematological parameters and also affecting serum Na+, Cl-, K+ levels along with gill Na+/K+-ATPase activity. The indicated variations oxidative stress enzymes superoxide dismutase, Catalase, glutathione peroxidase with relative elevation in lipid peroxidation (LPO) (22.47±0.198) compared to control groups. CeO2NPs at high concentration (25mg/L) revealed the alterations in neurotransmitter glutamate levels compared to control groups. Rise in glucose and decrease in plasma protein levels in response to both the concentrations was noted. Microscopic observations confirmed the tissue damages and alterations in gill architecture. By integrating all results obtained by short term exposure of juvenile carps to CeO2NPs at different doses, we reported nanoparticles have considerable deleterious effects on physiological and morphological condition of fishes.

The Effect of Dimethyl Sulfoxide on In Vitro Platelet Function

1976 ◽  
Vol 36 (01) ◽  
pp. 221-229 ◽  
Author(s):  
Charles A. Schiffer ◽  
Caroline L. Whitaker ◽  
Morton Schmukler ◽  
Joseph Aisner ◽  
Steven L. Hilbert
Keyword(s):  
Platelet Count ◽  
Platelet Aggregation ◽  
Dimethyl Sulfoxide ◽  
Platelet Function ◽  
Platelet Volume ◽  
Short Term ◽  
Platelet Factor ◽  
Short Term Exposure ◽  
Structural Abnormalities

SummaryAlthough dimethyl sulfoxide (DMSO) has been used extensively as a cryopreservative for platelets there are few studies dealing with the effect of DMSO on platelet function. Using techniques similar to those employed in platelet cryopreservation platelets were incubated with final concentrations of 2-10% DMSO at 25° C. After exposure to 5 and 10% DMSO platelets remained discoid and electron micrographs revealed no structural abnormalities. There was no significant change in platelet count. In terms of injury to platelet membranes, there was no increased availability of platelet factor-3 or leakage of nucleotides, 5 hydroxytryptamine (5HT) or glycosidases with final DMSO concentrations of 2.5, 5 and 10% DMSO. Thrombin stimulated nucleotide and 5HT release was reduced by 10% DMSO. Impairment of thrombin induced glycosidase release was noted at lower DMSO concentrations and was dose related. Similarly, aggregation to ADP was progressively impaired at DMSO concentrations from 1-5% and was dose related. After the platelets exposed to DMSO were washed, however, aggregation and release returned to control values. Platelet aggregation by epinephrine was also inhibited by DMSO and this could not be corrected by washing the platelets. DMSO-plasma solutions are hypertonic but only minimal increases in platelet volume (at 10% DMSO) could be detected. Shrinkage of platelets was seen with hypertonic solutions of sodium chloride or sucrose suggesting that the rapid transmembrane passage of DMSO prevented significant shifts of water. These studies demonstrate that there are minimal irreversible alterations in in vitro platelet function after short-term exposure to DMSO.

Inhibition of IL-13: A New Pathway for Atopic Dermatitis

2020 ◽  
pp. 120347542098255
Author(s):  
Kayadri Ratnarajah ◽  
Michelle Le ◽  
Anastasiya Muntyanu ◽  
Steve Mathieu ◽  
Simon Nigen ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Atopic Dermatitis ◽  
Severity Index ◽  
Severe Atopic Dermatitis ◽  
Treatment Alternative ◽  
Control Groups ◽  
Rapid Improvement ◽  
Common Receptor ◽  
The Common ◽  
And Control

Dupilumab, a monoclonal antibody against the common receptor of interleukin (IL)-4 and IL-13, was the first biologic therapy approved in Canada for treatment of moderate-to-severe atopic dermatitis (AD). While it is considered safe and effective, dupilumab is not universally effective and 8%-38% of patients develop conjunctivitis, while some patients develop head and neck dermatitis. Thus, new therapeutic options are warranted. While both IL-4 and IL-13 play important roles in the pathogenesis of AD, it has been recently demonstrated that IL-13 is the primary upregulated cytokine in AD skin biopsy samples. A placebo-controlled phase 2b clinical trial evaluating the efficacy and safety of lebrikizumab, an IL-13 inhibitor, in AD demonstrated that, at 16 weeks, Eczema Area and Severity Index (EASI) 75 and Investigator’s Global Assessment (IGA) 0/1 were achieved by 60.6% and 44.6% of patients taking lebrikizumab at its highest dose (vs 24.3% and 15.3% of patients taking placebo, respectively). Moreover, treatment with lebrikizumab was associated with rapid improvement of pruritus and low rates of conjunctivitis (1.4%-3.8%). Another IL-13 monoclonal antibody, tralokinumab, was evaluated for safety and efficacy in moderate-to-severe AD. By week 12, among adults receiving 300 mg tralokinumab, 42.5% achieved EASI-75 and 26.7% achieved IGA 0/1 score (vs 15.5% and 11.8% in the placebo group, respectively). Both lebrikizumab and tralokinumab demonstrated acceptable safety profiles in AD (and non-AD) trials with adverse events often being comparable between treatment and control groups. Thus, IL-13 inhibitors may provide a safe and effective treatment alternative for patients with moderate-to-severe AD.

Short-term exposure and long-term consequences of neonatal exposure to Δ9-tetrahydrocannabinol (THC) and ibuprofen in mice

2016 ◽  
Vol 307 ◽  
pp. 137-144 ◽  
Author(s):  
Gaëtan Philippot ◽  
Fred Nyberg ◽  
Torsten Gordh ◽  
Anders Fredriksson ◽  
Henrik Viberg
Keyword(s):  
Neonatal Exposure ◽  
Short Term ◽  
Short Term Exposure ◽  
Long Term Consequences
Sign in / Sign up

Export Citation Format

Share Document